查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
甲狀腺眼疾市場報告：至2030年的趨勢、預測與競爭分析
市場調查報告書
商品編碼
1356893

甲狀腺眼疾市場報告：至2030年的趨勢、預測與競爭分析

Thyroid Eye Disease Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

甲狀腺眼疾的趨勢和預測

預計到2030年，全球甲狀腺眼疾市場預計將達到 14 億美元，2024年至2030年年複合成長率為 8.1%。該市場的主要促進因素是增加自體免疫疾病治療，提高患者對治療的依從性以及改善醫療環境。全球甲狀腺眼疾市場的未來充滿希望，醫院和診所市場充滿機會。

甲狀腺眼疾市場洞察

  • Lucintel 預測單株抗體將在預測期內達到最高成長。
  • 醫院將繼續成為該市場的最大細分市場。
  • 由於醫療保健支出增加、疾病數量增加以及該地區主要企業投資增加，預計亞太地區將在預測期內實現最高成長。

本報告回答了 11 個關鍵問題：

  • Q.1.細分市場中最有前途和高成長的機會為何？
  • Q.2.哪個細分市場將以更快的速度成長？理由為何？
  • Q.3.哪些地區未來會出現更快的成長？理由為何？
  • Q.4.影響市場動態的主要因素有哪些？市場的主要挑戰和業務風險是什麼？
  • Q.5.這個市場的商業風險和競爭威脅為何？
  • Q.6.這個市場有哪些新趨勢？理由為何？
  • Q.7.市場客戶需求有何改變？
  • Q.8.該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10.該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球甲狀腺眼疾市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球甲狀腺眼疾市場趨勢（2018-2023）與預測（2024-2030）
  • 全球甲狀腺眼疾市場，按治療類型
    • 皮質類固醇
    • 維他命
    • 單株抗體
    • 其他
  • 全球甲狀腺眼疾市場，依給藥途徑
    • 口服
    • 局部
    • 胃腸外
  • 全球甲狀腺眼疾市場，依產品
    • 錠劑
    • 膠囊
    • 軟膏
    • 解決方案
  • 全球全球甲狀腺眼疾市場，依最終用途行業
    • 醫院
    • 診所
    • 其他

第4章 2018-2030年市場趨勢及預測分析，依地區

  • 全球甲狀腺眼疾市場，依地區
  • 北美洲甲狀腺眼疾市場
  • 歐洲甲狀腺眼疾市場
  • 亞太地區甲狀腺眼疾市場
  • 其他區域甲狀腺眼疾市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
  • 全球甲狀腺眼疾市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球甲狀腺眼疾市場的產能擴張
    • 全球甲狀腺眼疾市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • AbbVie
  • Novartis International
  • Teva Pharmaceutical Industries
  • Pfizer
  • Sanofi SA
  • Merck
  • Abbot Laboratories
  • Horizon Therapeutics
  • Johnson & Johnson
  • GE Healthcare
簡介目錄

Thyroid Eye Disease Trends and Forecast

The future of the global thyroid eye disease market looks promising with opportunities in the hospital and clinic markets. The global thyroid eye disease market is expected to reach an estimated $1.40 billion by 2030 with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are the growing incidence autoimmune disease treatment, increasing number of patient compliance for treatment, and improved healthcare settings.

A more than 150-page report is developed to help in your business decisions.

Thyroid Eye Disease by Segment

The study includes a forecast for the global thyroid eye disease by treatment type, route of administration, product, end use industry, and region.

Thyroid Eye Disease Market by Treatment Type [Shipment Analysis by Value from 2018 to 2030]:

  • Corticosteroids
  • Vitamins
  • Monoclonal Antibody
  • Others

Thyroid Eye Disease Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Oral
  • Topical
  • Parenteral

Thyroid Eye Disease Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Tablet
  • Capsule
  • Ointment
  • Solution

Thyroid Eye Disease Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics
  • Others

Thyroid Eye Disease Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Thyroid Eye Disease Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies thyroid eye disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the thyroid eye disease companies profiled in this report include-

  • Abbvie
  • Novartis International
  • Teva Pharmaceutical Industries
  • Pfizer
  • Sanofi S.A.
  • Merck
  • Abbot Laboratories
  • Horizon Therapeutics
  • Johnson & Johnson
  • GE Healthcare

Thyroid Eye Disease Market Insights

  • Lucintel forecasts that monoclonal antibody is expected to witness highest growth over the forecast period.
  • Within this market, hospitals will remain the largest segment.
  • APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, rising number of diseases, and rising investments by major players in the region.

Features of the Global Thyroid Eye Disease Market

  • Market Size Estimates: Thyroid Eye Disease Market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
  • Segmentation Analysis: Thyroid Eye Disease Market by various segments, such as by treatment type, route of administration, product, end use industry and region in terms of($B).
  • Regional Analysis: Thyroid Eye Disease Market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different treatment types, route of administrations, products, end use industries, and region.s for the thyroid eye disease market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the thyroid eye disease market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the thyroid eye disease market size?

Answer: The global thyroid eye disease market is expected to reach an estimated $1.40 billion by 2030.

Q.2. What is the growth forecast for thyroid eye disease market?

Answer: The global thyroid eye disease market is expected to grow with a CAGR of 8.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the thyroid eye disease market?

Answer: The major drivers for this market are the growing incidence autoimmune disease treatment, increasing number of patient compliance for treatment, and improved healthcare settings.

Q.4. What are the major segments for thyroid eye disease market?

Answer: The future of the thyroid eye disease market looks promising with opportunities in the hospital and clinic markets.

Q.5. Who are the key thyroid eye disease market companies?

Answer: Some of the key thyroid eye disease companies are as follows:

  • AbbVie
  • Novartis International
  • Teva Pharmaceutical Industries
  • Pfizer
  • Sanofi S.A.
  • Merck
  • Abbot Laboratories
  • Horizon Therapeutics
  • Johnson & Johnson
  • GE Healthcare

Q.6. Which thyroid eye disease market segment will be the largest in future?

Answer: Lucintel forecasts that monoclonal antibody is expected to witness highest growth over the forecast period.

Q.7. In thyroid eye disease market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to increasing healthcare expenditure, rising number of diseases, and rising investments by major players in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the thyroid eye disease market by treatment type (corticosteroids, vitamins, monoclonal antibody, and others), route of administration (oral, topical, and parenteral), product (tablet, capsule, ointment, and solution), end use industry (hospitals, clinics, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Thyroid Eye Disease Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Thyroid Eye Disease Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Thyroid Eye Disease Market by Treatment Type
    • 3.3.1: Corticosteroids
    • 3.3.2: Vitamins
    • 3.3.3: Monoclonal Antibody
    • 3.3.4: Others
  • 3.4: Global Thyroid Eye Disease Market by Route of Administration
    • 3.4.1: Oral
    • 3.4.2: Topical
    • 3.4.3: Parenteral
  • 3.5: Global Thyroid Eye Disease Market by Product
    • 3.5.1: Tablet
    • 3.5.2: Capsule
    • 3.5.3: Ointment
    • 3.5.4: Solution
  • 3.6: Global Thyroid Eye Disease Market by End Use Industry
    • 3.6.1: Hospitals
    • 3.6.2: Clinics
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Thyroid Eye Disease Market by Region
  • 4.2: North American Thyroid Eye Disease Market
    • 4.2.1: North American Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
    • 4.2.2: North American Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others
  • 4.3: European Thyroid Eye Disease Market
    • 4.3.1: European Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
    • 4.3.2: European Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others
  • 4.4: APAC Thyroid Eye Disease Market
    • 4.4.1: APAC Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
    • 4.4.2: APAC Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others
  • 4.5: ROW Thyroid Eye Disease Market
    • 4.5.1: ROW Thyroid Eye Disease Market by Treatment Type: Corticosteroids, Vitamins, Monoclonal Antibody, and Others
    • 4.5.2: ROW Thyroid Eye Disease Market by End Use Industry: Hospitals, Clinics, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Thyroid Eye Disease Market by Treatment Type
    • 6.1.2: Growth Opportunities for the Global Thyroid Eye Disease Market by Route of Administration
    • 6.1.3: Growth Opportunities for the Global Thyroid Eye Disease Market by Product
    • 6.1.4: Growth Opportunities for the Global Thyroid Eye Disease Market by End Use Industry
    • 6.1.5: Growth Opportunities for the Global Thyroid Eye Disease Market by Region
  • 6.2: Emerging Trends in the Global Thyroid Eye Disease Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Thyroid Eye Disease Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Thyroid Eye Disease Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: AbbVie
  • 7.2: Novartis International
  • 7.3: Teva Pharmaceutical Industries
  • 7.4: Pfizer
  • 7.5: Sanofi S.A.
  • 7.6: Merck
  • 7.7: Abbot Laboratories
  • 7.8: Horizon Therapeutics
  • 7.9: Johnson & Johnson
  • 7.10: GE Healthcare